Home » Topics » BioWorld Science

BioWorld Science
RSS

Kissei Pharmaceutical synthesizes new TRPM8 antagonists

July 19, 2018

Global Blood Therapeutics patents EHMT2 inhibitors

July 19, 2018

Incyte presents PD-1/PD-L1 interaction inhibitors

July 19, 2018

Nampt inhibition with OT-82 shows promise in xenograft leukemia models

July 19, 2018

Aquinnah Pharmaceuticals divulges TDP-43 aggregation inhibitors

July 19, 2018

Daiichi Sankyo and collaborator patent TNSALP inhibitors

July 19, 2018

Phase III study of subcutaneous vedolizumab in ulcerative colitis meets primary endpoint

July 19, 2018

FDA approves Kisqali for HR-positive HER-negative advanced or metastatic breast cancer

July 19, 2018

Vyriad collaborates with Merck KGaA and Pfizer to study Voyager-V1 with avelumab

July 19, 2018

Incyte studies INCB-054707 for hidradenitis suppurativa in phase II trial

July 19, 2018

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...